← Open Payments lookup

MOUZIANE DEEB: Open Payments

NPI 1720102833 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$513 in 26 payments from 18 companies in 2025. Trend: 2023 $114 · 2024 $56 · 2025 $513

Food & beverage: $513
CompanyPaymentsAmount
Myriad Genetic Laboratories, Inc.3$58
AstraZeneca Pharmaceuticals LP3$58
Lilly USA, LLC3$54
Boehringer Ingelheim Pharmaceuticals, Inc.3$53
Medtronic, Inc.1$35
Janssen Biotech, Inc.1$28
SOBI, INC1$24
Geron Corporation1$24
Merck Sharp & Dohme LLC1$21
Stemline Therapeutics Inc.1$21

Products named: MYRISK, JARDIANCE, SYNCHROMEDII, MOUNJARO, DARZALEX, Doptelet, RYTELO, KEYTRUDA.

Industry payments across OK — which companies pay providers there.